Flagship Ventures Fund IV General Partner LLC Insider Trading $RUBY Rubius Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is 10% Owner in Seres Therapeutics, Inc. ($MCRB) and 10% Owner in Axcella Health Inc. ($AXLA) and Director in Moderna, Inc. ($MRNA) and 10% Owner in Evelo Biosciences, Inc. ($EVLO) and 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and Director in Rubius Therapeutics, Inc. ($RUBY) and 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and Director in Kaleido Biosciences, Inc. ($KLDO) and 10% Owner in TransMedics Group, Inc. ($TMDX).

Flagship Ventures Fund IV General Partner LLC in Rubius Therapeutics, Inc.

Trading Symbol: RUBY
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner, Director
Holdings: 15,393,593 shares
Latest Transaction: Mar 23 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC in Rubius Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	2,633,703	2.6 M to 2.6 M (+2.73 %)
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	5,859,414	5.8 M to 5.9 M (+1.21 %)
Mar 23 2021	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	29.00	70,000	2,030,000	15,393,593	15.3 M to 15.4 M (+0.46 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	781,860	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	195,466	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	195,466	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	1,781,843	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	593,948	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	593,948	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	5,000,000	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	5,000,000	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	3,830,402	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Option Exercise	C	0.00	15,323,593	0	0
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	781,860	0	2,563,703	1.8 M to 2.6 M (+43.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	195,466	0	5,789,414	5.6 M to 5.8 M (+3.49 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	195,466	0	5,789,414	5.6 M to 5.8 M (+3.49 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	1,781,843	0	1,781,843	0 to 1.8 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	593,948	0	5,593,948	5 M to 5.6 M (+11.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	593,948	0	5,593,948	5 M to 5.6 M (+11.88 %)
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	5,000,000	0	5,000,000	0 to 5 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	5,000,000	0	5,000,000	0 to 5 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	3,830,402	0	3,830,402	0 to 3.8 M
Jul 23 2018	RUBY	Rubius Therapeutic ...	Flagship Ventures Fund IV Gene ...	Director	Buy	C	0.00	15,323,593	0	15,323,593	0 to 15.3 M

Page: 1